Conavi Medical's new hybrid imaging system simultaneously performs IVUS and OCT.

Heart Rhythm 2026 in Chicago will include a total of 18 late-breaking clinical trials—and that is just the beginning. The four-day event kicks off April 23.

Gregg Stone, MD, spoke to Cardiovascular Business about the lessons he and his colleagues learned from the STEMI DTU trial.

The FDA asked, and Eli Lilly and Company delivered. The company now hopes to secure an additional approval for orforglipron/Foundayo that covers the treatment of type 2 diabetes.

Cardiologists in the United States now earn an average annual income of $575,000. That represents an increase of 10% compared to the previous year.

New 10-year data explored the impact of performing SAVR on asymptomatic patients with severe aortic stenosis.

The new clinic wants to keep patients out of hospital EDs when possible and provide care at a lower cost.

The family of a teenage girl who died unexpectedly in 2025 has sued two energy drink distributors.

AI can help care teams get additional value out of routine head CT images.

Landiolol, sold under the brand name Rapiblyk, is only meant to be administered in a hospital setting. It was initially approved for adult patients in 2024.